Hologic completed the acquisition of Endomagnetics for $310m.

Hologic, a United States medical technology company primarily focused on women's health, completed the acquisition of Endomagnetics, a medical device manufacturer, for $310m. “We are thrilled to complete the acquisition of Endomag and are looking forward to working with our new colleagues to increase access to their innovative technologies, which complement and diversify our expanding interventional breast health portfolio. With our shared commitment to advancing women’s health globally, we are excited to improve outcomes for patients and, together with our customers, redefine the standard of care for breast cancer intervention,” Erik Anderson, Hologic President.